Venous Obstruction
0
Pipeline Programs
1
Companies
2
Clinical Trials
2 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
InterVeneCA - Redwood City
2 programsRecana Thrombectomy Catheter SystemN/A1 trial
Recana procedureN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2025
2026
2027
InterVeneRecana Thrombectomy Catheter System
InterVeneRecana procedure
Clinical Trials (2)
Total enrollment: 50 patients across 2 trials
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-UK)
Start: Oct 2025Est. completion: Jul 202730 patients
N/ARecruiting
RECANA OUS - Recana Thrombectomy Catheter System for Venous Obstruction and Occlusion Study (RECANA-OUS-IRL)
Start: Jul 2025Est. completion: Apr 202720 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 actively recruiting trials targeting 50 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.